News for 'Lupin Pharmaceuticals'

Earnings of Sensex companies: March to be best in 7 quarters

Earnings of Sensex companies: March to be best in 7 quarters

Rediff.com11 Apr 2016

Combined net profit estimated to grow 14.6% year-on-year, against a 5.7% decline in the Dec 2015 quarter

Ask Ajit: 'Bought shares at peak; please advice'

Ask Ajit: 'Bought shares at peak; please advice'

Rediff.com30 Mar 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Weakness in global stocks take shine off markets

Weakness in global stocks take shine off markets

Rediff.com3 May 2016

The S&P BSE Sensex dropped 207 points to end at 25,230.

What goodies will Xi Jinping get for India?

What goodies will Xi Jinping get for India?

Rediff.com17 Sep 2014

Investment announcement for $100 bn over 5 years likely.

Drugmakers draw more FDA scrutiny as US imports rise

Drugmakers draw more FDA scrutiny as US imports rise

Rediff.com13 Sep 2013

And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.

Mukesh Ambani's wealth grew 67% last year, is India's richest for 10th time

Mukesh Ambani's wealth grew 67% last year, is India's richest for 10th time

Rediff.com5 Oct 2017

Forbes said Prime Minister Narendra Modi's "economic experiments" barely affected India's billionaires while none gained more than oil-and-gas tycoon Mukesh Ambani, who cemented his decade-long hold on the top slot by adding a staggering USD 15.3 billion (67 per cent) to his last year's wealth to become one of Asia's top five richest.

Sensex ends 310 points lower; highest single-day loss since Brexit

Sensex ends 310 points lower; highest single-day loss since Brexit

Rediff.com10 Aug 2016

Bank shares were the top losers along with index heavyweight RIL

Profit boom amid sales gloom

Profit boom amid sales gloom

Rediff.com8 Jul 2013

Brokerages expect Nifty50 firms to post 11.8% growth in net profit in Q1 but sales may decline

Stocks that shine year after year

Stocks that shine year after year

Rediff.com31 Dec 2014

The S&P BSE Sensex has rallied about 28 per cent in 2014, after formation of a stable government at the Centre.

Ask Ajit: 'Help! I have inherited these stocks...'

Ask Ajit: 'Help! I have inherited these stocks...'

Rediff.com23 Nov 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

RBI policy to set the tone for markets

RBI policy to set the tone for markets

Rediff.com3 Apr 2016

The BSE Mid-cap index gained 1.1% while the Small-cap index surged 1.3%, outperforming the benchmark indices

Markets ends flat; Sensex posts best monthly gain in over 4 years

Markets ends flat; Sensex posts best monthly gain in over 4 years

Rediff.com31 Mar 2016

The S&P BSE Sensex ended the session at 25,342, up 3 points while the Nifty50 closed at 7,738 points.

Markets fall for 6th straight session; Sun Pharma dips 2%

Markets fall for 6th straight session; Sun Pharma dips 2%

Rediff.com21 Dec 2016

Sun Pharma dipped 2% to Rs 615 on the BSE, its lowest level since November 9, 2016

Pill for thought: Sweetheart deals that hurt consumers

Pill for thought: Sweetheart deals that hurt consumers

Rediff.com16 Sep 2014

'Pay-for-delay' settlements between drug patent-holders and generics manufacturers to delay the launch of cheaper generic medicine are increasingly being scrutinised by antitrust regulators

Markets end in the green ahead of F&O expiry

Markets end in the green ahead of F&O expiry

Rediff.com23 Nov 2016

Broader market outperformed the headline indices with BSE Midcap and Smallcap finishing the day 1.22%, and 1.54% higher, respectively

Daiichi and Docomo go, but India remains a hot market for the Japanese

Daiichi and Docomo go, but India remains a hot market for the Japanese

Rediff.com27 Apr 2014

While the two high-profile exits in pharmaceutical and telecom have raised concerns over regulatory hassles in the country, Japanese investors are still keen to tap into India's consumer growth story and many more merger and acquisition deals are in the offing in this space.

Markets pause after record breaking spree on profit taking

Markets pause after record breaking spree on profit taking

Rediff.com20 Aug 2014

The Nifty had hit its third successive record high of 7,922.70 today.

Stock advice: Readers' queries answered!

Stock advice: Readers' queries answered!

Rediff.com14 Aug 2019

Ajit Mishra, Vice President, Research, Religare Broking, answers readers' stock market queries. Ajit will offer his unbiased views on a weekly basis

Sensex ends 100 points higher after rupee, China shares rebound

Sensex ends 100 points higher after rupee, China shares rebound

Rediff.com19 Aug 2015

Bharti Airtel , RCom and Tata Communications ended down between 0.1-1%.

'Indian equities will outshine emerging markets'

'Indian equities will outshine emerging markets'

Rediff.com1 Jul 2016

'We have seen a host of businesses across sectors generate economic value and wealth for investors.'

Prices of key diabetes, cancer drugs may drop by 25%

Prices of key diabetes, cancer drugs may drop by 25%

Rediff.com8 Mar 2018

A recent report has suggested that future patent expires in the cardiac and anti-diabetes space would form a good opportunity for smaller firms, given their franchise in these segments.

Markets touch 19-month closing low on dismal Q3 earnings

Markets touch 19-month closing low on dismal Q3 earnings

Rediff.com15 Jan 2016

The S&P BSE Sensex closed 318 points at 24,455 and the Nifty50 shed 99 points to end at 7,438.

Pharma stocks could rise another 15-20%

Pharma stocks could rise another 15-20%

Rediff.com28 Jul 2014

Expectations of strong results, consistent performance and investors preference for stocks in the defensive space help the sector outshine broader markets.

Sensex ends over 200 points lower on weak European cues

Sensex ends over 200 points lower on weak European cues

Rediff.com28 Sep 2015

Investors will maintain a cautious stance.

Weak rupee, China woes drag Sensex below 25,000; Nifty breaches 7,600

Weak rupee, China woes drag Sensex below 25,000; Nifty breaches 7,600

Rediff.com7 Sep 2015

The Sensex closed down 308 points at 24,894 and the Nifty has lost 96 points at 7,559.

Sensex cracks 354 points on yuan devaluation, GST deadlock

Sensex cracks 354 points on yuan devaluation, GST deadlock

Rediff.com12 Aug 2015

The rupee fell to a two-year low of 64.84 against the US dollar.

Markets snap 4-day losing streak; IT, auto top gainers

Markets snap 4-day losing streak; IT, auto top gainers

Rediff.com29 Jul 2015

Sensex, Nifty slightly upbeat, midcaps to rule markets this week.

Greece 'No' doesn't affect markets; Sensex, Nifty end in green

Greece 'No' doesn't affect markets; Sensex, Nifty end in green

Rediff.com6 Jul 2015

The recovery was led by pharma majors led by Dr Reddy's Labs.

Markets make handsome gains on RBI's stance, global cues

Markets make handsome gains on RBI's stance, global cues

Rediff.com7 Jun 2016

ICICI Bank and SBI were among the top Sensex gainers along with FMCG majors ITC and HUL.

Sensex gains nearly 100 points ahead of July F&O expiry

Sensex gains nearly 100 points ahead of July F&O expiry

Rediff.com30 Jul 2014

Sensex gained nearly 0.4% or 96 points at 26087 level while Nifty ended up by 42 points or 0.5% at 7,791.40 level.

Sensex, Nifty post best gain in a month

Sensex, Nifty post best gain in a month

Rediff.com30 Mar 2016

Broader markets are outperforming the benchmark indices- BSE Midcap and Smallcap indices are up 0.8%-1%.

Sensex tumbles 93 points, Nifty breaches 8,200

Sensex tumbles 93 points, Nifty breaches 8,200

Rediff.com1 Dec 2016

Telecom stocks fell after Mukesh Ambani extended Reliance Jio's free offers till March 2017.

New dividend tax to hurt Premji, Mukesh Ambani the most

New dividend tax to hurt Premji, Mukesh Ambani the most

Rediff.com2 Mar 2016

Additional levy to eat into Rs 6,000-crore income of top promoters

Time for Indian pharma cos to change strategies

Time for Indian pharma cos to change strategies

Rediff.com1 Aug 2014

It's time for Indian generic companies to rethink their strategies.

Sensex drops 244 points on weak eco data, Fed caution

Sensex drops 244 points on weak eco data, Fed caution

Rediff.com15 Sep 2014

HDFC, TCS, RIL, ITC and ICICI Bank dragged the Sensex by over 100 points.

Economic recovery: Will India Inc get third time lucky?

Economic recovery: Will India Inc get third time lucky?

Rediff.com6 Jun 2016

This analysis is based on the quarterly earnings for 724 companies.

Sensex rebounds 190 points to end at 23,382

Sensex rebounds 190 points to end at 23,382

Rediff.com17 Feb 2016

The S&P BSE Sensex ended 190 points up at 23,382.

Markets end near 1-month high; Sensex reclaims 26,000

Markets end near 1-month high; Sensex reclaims 26,000

Rediff.com28 Dec 2015

Investors will remain cautious ahead of F&O expiry.

IT, pharma rally expected to continue

IT, pharma rally expected to continue

Rediff.com10 Jan 2014

Another year of strong performance by these export-oriented sectors likely as US economy revives and rupee is expected to be under pressure.

Markets end flat amid volatility

Markets end flat amid volatility

Rediff.com24 Sep 2013

Markets snapped two-day losing streak and ended flat with a positive bias on Tuesday as gains in auto shares helped offset losses in IT majors.